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ABSTRACT 
With metastasis accounting for approximately 90% of breast cancer deaths and an alarming number of 
over 300,000 new breast cancer cases to be diagnosed by the end of 2018, there is growing need to 
understand the process of breast cancer. Changes in the extracellular matrix (ECM) of the tumor 
microenvironment play an essential role in this deadly tumor progression. Specifically, the glycoprotein 
fibronectin (FN), has been identified to be up-regulated in patients with worse clinical outcomes. During 
tumor progression fibronectin undergoes conformational changes that aid in metastatic dissemination. In 
order to analyze the dynamic changes in FN expression and evaluate architectural changes within the 
metastatic niche, electrophoretic tissue clearing was used to image changes in whole murine lungs that 
have undergone breast cancer metastasis. The X-CLARITY tissue clearing system utilizes 
electrophoresis which removes the lipid compounds from tissues to make them optically transparent. 
Coupling this with the c-PRESTO immuno-labelling technique and confocal light microscopy allows 
imaging of FN expression and structure in whole murine organs. In this study, a tissue clearing, and 
staining protocol was developed and used to visualize the 3D FN structure in whole murine lungs. Future 
studies will evaluate changes in FN expression and structure over time during cancer progression. This 
would contribute to on-going research on the development of more effective breast cancer drugs that aim 
to combat metastasis.  
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